About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Government price setting in any form is bad for American patients and undermines the U.S. biopharmaceutical industry’s ability to compete against other countries. Foreign reference pricing (FRP) policies are a form of government price controls that effectively outsource authority to nations that often undervalue biopharmaceutical innovation.
Foreign Reference Pricing is Bad for Americans teaser
Fact Sheet
Government Price Setting
Foreign Reference Pricing is Bad for Americans
Foreign Reference Pricing is Bad for Americans teaser